Key Points
- CEO Sean Duffy sold 12,942 Omada Health shares at an average price of $24.81, totaling $321,091.02. He retained 411,861 shares after the transaction, disclosed in an SEC filing.
- Omada Health recently reported quarterly EPS of $0.08, beating estimates by $0.10, while revenue of $87.83 million exceeded expectations of $80.93 million.
- Analysts maintain a generally positive outlook, with 11 Buy ratings, two Holds and one Sell; the stock has a “Moderate Buy” consensus and an average price target of $25.67. Institutional investors including BlackRock and Perceptive Advisors also recently established positions.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 8,628 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $21.85, for a total transaction of $188,521.80. Following the transaction, the chief executive officer owned 411,861 shares of the company's stock, valued at approximately $8,999,162.85. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Omada Health Stock Down 3.9%
Shares of OMDA opened at $24.01 on Wednesday. The stock has a market cap of $1.47 billion, a PE ratio of 480.20 and a beta of 1.73. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The business has a 50-day simple moving average of $20.61 and a two-hundred day simple moving average of $16.32.
Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. The firm had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. On average, equities research analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.
Institutional Investors Weigh In On Omada Health
A number of hedge funds have recently added to or reduced their stakes in the company. Quarry LP bought a new stake in shares of Omada Health during the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. bought a new position in shares of Omada Health in the 4th quarter worth $32,000. Raymond James Financial Inc. acquired a new stake in Omada Health in the 2nd quarter valued at $32,000. Inlight Wealth Management LLC acquired a new stake in Omada Health in the 4th quarter valued at $45,000. Finally, Versant Capital Management Inc increased its stake in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on OMDA. Citizens Jmp increased their price target on Omada Health from $21.00 to $27.00 and gave the company a "market outperform" rating in a research note on Monday, July 20th. BTIG Research lifted their price objective on Omada Health from $30.00 to $35.00 and gave the stock a "buy" rating in a research note on Monday. Weiss Ratings downgraded shares of Omada Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday, July 13th. Barclays raised their price target on shares of Omada Health from $20.00 to $25.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Finally, BMO Capital Markets reaffirmed an "outperform" rating and issued a $24.00 price objective on shares of Omada Health in a research note on Friday. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Omada Health currently has a consensus rating of "Moderate Buy" and an average target price of $25.67.
Get Our Latest Report on Omada Health
About Omada Health
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
